Showing results (71-80 of 87) with videos related to

Sort By:
Pageof 9
Frontiers in Pharmacology|January 10, 2017
Prognostic and Predictive Factors in Patients with Advanced Penile Cancer Receiving Salvage (2nd or Later Line) Systemic Treatment: A Retrospective, Multi-Center StudyCarlo Buonerba, Giuseppe Di Lorenzo, Gregory Pond, et al.
European Journal of Cancer (Oxford, England : 1990)|October 7, 2020
A randomised trial of 4- versus 12-weekly administration of bone-targeted agents in patients with bone metastases from breast or castration-resistant prostate cancerMark Clemons, Michael Ong, Carol Stober, et al.
Breast Cancer Research and Treatment|August 21, 2025
Patient perceptions around the use of clinico-pathologic and genomic tools in the management of early breast cancerAna-Alicia Beltran-Bless, Deanna Saunders, Lucas Clemons, et al.
Current Oncology (Toronto, Ont.)|August 28, 2024
A Randomized Trial Comparing Concurrent versus Sequential Radiation and Endocrine Therapy in Early-Stage, Hormone-Responsive Breast CancerSharon F McGee, Mark Clemons, Gregory Pond, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|December 4, 2018
A prospective intervention to improve happiness and reduce burnout in oncologistsMark Clemons, Sasha Mazzarello, Gregory Pond, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 12, 2024
Validation of the Prognostic Performance of Breast Cancer Index in Hormone Receptor-Positive Postmenopausal Breast Cancer Patients in the TEAM TrialJohn M S Bartlett, Keying Xu, Jenna Wong, et al.
Medicine|June 15, 2017
PSA declines and survival in patients with metastatic castration-resistant prostate cancer treated with enzalutamide: A retrospective case-report studyDavide Bosso, Martina Pagliuca, Guru Sonpavde, et al.
Gynecologic Oncology|May 5, 2023
Surgical margin status in relation to surgical approach in the management of early-stage cervical Cancer: A Canadian cervical Cancer collaborative (4C) studySabrina Piedimonte, Limor Helpman, Gregory Pond, et al.
Radiation Oncology (London, England)|November 8, 2024
Growth differentiation factor 15 (GDF15) predicts relapse free and overall survival in unresected locally advanced non-small cell lung cancer treated with chemoradiotherapyFiorella Di Pastena, Gregory Pond, Evangelia E Tsakiridis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 2, 2011
Evaluating survivorship care plans: results of a randomized, clinical trial of patients with breast cancerEva Grunfeld, Jim A Julian, Gregory Pond, et al.
Pageof 9